GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I’ve investigated whether this is the case. When investing, your capital is ...

Following the release of Gary Hustwit's long-awaited Eno documentary, our resident music prof puts the fabled producer's most celebrated release under the musical microscope When you purchase through ...

Brian Eno’s studio in Notting Hill is tucked away at the end of a cobbled mews, its facade a quarter of the normal size. The effect is like a kind of fairy-door, and as you enter, it opens on to ...

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

Legendary British musician and visual artist Brian Eno is stepping back into the world of words. His highly anticipated "What Art Does: An Unfinished Theory", co-authored with Dutch artist and ...

Brand New Membership Level: Benzinga Trade Alerts GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from existing assets. At the JPMorgan Healthcare ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...

Eli Lilly made a $2.5 billion deal for a breast cancer drug; GSK reached a $1 billion-plus deal for IDRx. The announcements suggest a potential rebound in M&A deals in the healthcare sector for 2025.

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

The group is made up of tech entrepreneurs, scholars and various advocates including actor Mark Ruffalo, filmmaker Alex Winter, musician Brian Eno and Wikipedia founder Jimmy Wales. It is leading ...

GSK has agreed to buy US biopharmaceutical business IDRx in a deal worth up to $1.15billion (£1billion). Under the agreement, GSK will pay $1billion upfront to acquire the Massachusetts-based ...

January 13, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...